Adom Health: Franchising a Pharmacy Chain
Adom Health Ltd runs 38 company-owned pharmacies in Ghana with revenue of GHS 210 million and return on invested capital of 18%, against an estimated WACC of 21%. The managing director proposes 100 franchise outlets over three years to reach underserved regional capitals. Franchisees would pay GHS 250,000 upfront and 5% of monthly sales; Adom would supply 80% of stock from its central warehouse and provide the brand, IT and training. The Pharmacy Council requires each outlet to have a registered superintendent pharmacist, and Adom's current stores already report 14% annual pharmacist turnover. Company-owned expansion would need GHS 9 million per store and is constrained by GHS 60 million of debt covenant headroom. A pilot of five franchises in Kumasi achieved 91% brand-compliance scores, but two franchisees under-reported sales in the first quarter.
1. Assess the franchise proposal using Ansoff's matrix and the concept of strategic fit, and explain the main capability gaps Adom must close.
Read the worked answer
Under Ansoff, the proposal is primarily market development: the existing pharmacy retail offer is taken to new regional markets through a new channel. It has elements of diversification because franchising is a different operating model from company-owned stores, but the product-market logic is market development.
Strategic fit. The proposal fits Adom's brand, central warehouse and IT platform. It leverages existing buying power and allows growth with less capital than company-owned stores. At GHS 9 million per company-owned store, 100 stores would require GHS 900 million, far beyond the GHS 60 million covenant headroom. Franchising converts capital expenditure into franchisee capital and creates fee income. On the surface it addresses the growth constraint.
But fit is weak in control capabilities. The pilot shows 91% brand compliance, which is acceptable but not strong, and two franchisees under-reported sales. That is a control failure in the revenue-share model, not a minor pilot issue. Adom's core capability is operating stores, not policing independent owners. Franchise systems require site selection, franchisee selection, contract enforcement, POS data integration, mystery shopping and termination capability. Adom appears to have none of these at scale.
Pharmacist capability is a second gap. Every outlet needs a superintendent pharmacist, and 14% turnover in company stores suggests the labour market is tight. One hundred franchises would require 100 superintendent pharmacists; if Adom cannot staff its own stores reliably, it cannot assume franchisees will. Training and retention become strategic bottlenecks.
Conclusion. The proposal is strategically attractive but operationally underdeveloped. It should be treated as a capability-building programme, not a property transaction. A staged rollout with a smaller first wave is more consistent with the evidence than a 100-store target.
2. Recommend an implementation plan and control framework for the franchise proposal, including how Adom should respond to the under-reporting issue.
Read the worked answer
The plan should be stage-gated and evidence-led.
Stage 1 - Fix the model (months 1–4). Extend the Kumasi pilot to 12 outlets, not 100. Install integrated POS systems that report sales directly to Adom, with a contractual right to audit and a penalty for under-reporting. Require franchisees to use Adom's inventory system for the 80% supplied stock. Test unit economics at outlet level: upfront fee, royalty, gross margin on supplied stock and local operating costs. Set a go/no-go threshold, for example 90% sales-data integrity and 95% brand compliance.
Stage 2 - Build the franchise capability (months 3–9). Appoint a franchise manager with retail operations experience. Write a franchise manual covering pricing, storage, pharmacovigilance, customer complaints and brand standards. Establish a franchisee selection scorecard: capital, pharmacy experience, local presence, willingness to accept systems. Create a superintendent pharmacist recruitment and retention plan, including a relief pool and continuing education.
Stage 3 - Scale (months 9–36). Roll out in clusters around existing distribution routes so that central warehouse economics work. Cap the first year at 25 outlets and review before each tranche.
Controls for under-reporting. The two Kumasi cases should be treated as a design flaw, not simply dishonesty. Response: (1) mandatory POS integration with daily data feeds; (2) royalty calculated on system data, not self-declared sales; (3) right to inspect and terminate; (4) mystery shopping and stock reconciliation; (5) a whistleblowing channel. The franchise contract must make data access a condition of the brand licence. Finally, the board should monitor leading indicators - pharmacist vacancies, royalty collection days, brand audit scores - not just outlet count.